|
|
Previous Article | Table of Contents | Next Article 
Blood, Vol. 95 No. 4 (February 15), 2000:
pp. 1350-1355
Circulating forms of intercellular adhesion molecule (ICAM)-1
in mice lacking membranous ICAM-1
Natasja K. van den Engel,
Edmund Heidenthal,
Antje Vinke,
Hubert Kolb, and
Stephan Martin
From the Clinical Department, Diabetes Research Institute at the
Heinrich Heine University, Düsseldorf, Germany
Mice deficient in intercellular adhesion molecule-1 (ICAM-1),
lacking membranous ICAM-1, show a normal development but abnormalities of inflammatory and immune functions. Although the membrane-bound form
of ICAM-1 is not detectable in the mutant strain, circulating ICAM-1
(cICAM) is present in serum from ICAM-1-deficient mice in similar
amounts as in serum from wild-type mice. These findings were confirmed
in vitro by flow cytometric analysis of lipopolysaccharide-stimulated spleen cells, and cICAM-enzyme-linked immunosorbent assay analysis of
supernatants of cultured spleen cells. To analyze for the source of
cICAM-1, spleen cell RNA was isolated and ICAM-1 RNA was amplified by
reverse transcriptase-polymerase chain reaction using primers binding
in the 5' and 3' untranslated regions. Different fragments were cloned and sequenced. In wild-type RNA the common 5 domain form of
ICAM-1 was identified. In RNA from ICAM-1 mutant mice only 3 smaller
fragments were found. Sequencing these fragments identified 3 alternatively spliced isoforms of ICAM-1, lacking 2 or 3 extracellular
domains. However, in all spliced fragments the transmembrane domain was
included. Therefore, we postulate that circulating forms of ICAM-1 are
generated by proteolytic cleavage of membranous ICAM-1. The data
indicate that the expression of membranous ICAM-1 and the appearance of
circulating forms in serum are independently regulated mechanisms.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. C. Bullard, X. Hu, T. R. Schoeb, R. G. Collins, A. L. Beaudet, and S. R. Barnum
Intercellular Adhesion Molecule-1 Expression Is Required on Multiple Cell Types for the Development of Experimental Autoimmune Encephalomyelitis
J. Immunol.,
January 15, 2007;
178(2):
851 - 857.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. K. Brake, E. O. Smith, H. Mersmann, C. W. Smith, and R. L. Robker
ICAM-1 expression in adipose tissue: effects of diet-induced obesity in mice
Am J Physiol Cell Physiol,
December 1, 2006;
291(6):
C1232 - C1239.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Mendez, S. B. Morris, S. Wilcoxen, E. Greeson, B. Moore, and R. Paine III
Shedding of soluble ICAM-1 into the alveolar space in murine models of acute lung injury
Am J Physiol Lung Cell Mol Physiol,
May 1, 2006;
290(5):
L962 - L970.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Watts, F. J. M. Beurskens, I. Martin-Padura, C. M. Ballantyne, L. B. Klickstein, M. B. Brenner, and D. M. Lee
Manifestations of Inflammatory Arthritis Are Critically Dependent on LFA-1
J. Immunol.,
March 15, 2005;
174(6):
3668 - 3675.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Dunne, R. G. Collins, A. L. Beaudet, C. M. Ballantyne, and K. Ley
Mac-1, but Not LFA-1, Uses Intercellular Adhesion Molecule-1 to Mediate Slow Leukocyte Rolling in TNF-{alpha}-Induced Inflammation
J. Immunol.,
December 1, 2003;
171(11):
6105 - 6111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Todaro, F. Di Gaudio, M. Lavitrano, G. Stassi, and G. Papaccio
Islet {beta}-Cell Apoptosis Triggered in Vivo by Interleukin-1{beta} Is Not Related to the Inducible Nitric Oxide Synthase Pathway: Evidence for Mitochondrial Function Impairment and Lipoperoxidation
Endocrinology,
October 1, 2003;
144(10):
4264 - 4271.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Sakurai, H. Taguchi, A. Anand, B. K. Ambati, E. S. Gragoudas, J. W. Miller, A. P. Adamis, and J. Ambati
Targeted Disruption of the CD18 or ICAM-1 Gene Inhibits Choroidal Neovascularization
Invest. Ophthalmol. Vis. Sci.,
June 1, 2003;
44(6):
2743 - 2749.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Mizgerd, M. R. Spieker, and M. M. Lupa
Exon truncation by alternative splicing of murine ICAM-1
Physiol Genomics,
December 26, 2002;
12(1):
47 - 51.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Lohmann, S. Laue, U. Nietzschmann, T.M. Kapellen, I. Lehmann, S. Schroeder, R. Paschke, and W. Kiess
Reduced Expression of Th1-Associated Chemokine Receptors on Peripheral Blood Lymphocytes at Diagnosis of Type 1 Diabetes
Diabetes,
August 1, 2002;
51(8):
2474 - 2480.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Graciano, D. D. Bryant, D. J. White, J. Horton, N. E. Bowles, and B. P. Giroir
Targeted disruption of ICAM-1, P-selectin genes improves cardiac function and survival in TNF-{alpha} transgenic mice
Am J Physiol Heart Circ Physiol,
April 1, 2001;
280(4):
H1464 - H1471.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |